Literature DB >> 26084772

Imaging findings of anaplastic astrocytoma in a child with maple syrup urine disease: a case report.

Jessie Aw-Zoretic1, Nitin R Wadhwani, Rishi R Lulla, Lulla R Rishi, Maura E Ryan.   

Abstract

Maple syrup urine disease (MSUD) is an inborn error of branched-chain amino acid metabolism, which usually presents in childhood with encephalopathy due to cerebral edema and dysmyelination. Even with treatment, metabolic stressors may precipitate later episodes of acute decompensation. Changes related to cerebral and white matter edema have been described by magnetic resonance imaging (MRI), and imaging can aid in both initial diagnosis and evaluation of decompensation. To date, there are no published known reports of cancer in patients with MSUD. Here, we present the first case report of an anaplastic astrocytoma in a teenager with MSUD, with a discussion of imaging findings and the use of magnetic resonance spectroscopy (MRS) to help distinguish between tumor and metabolic changes.

Entities:  

Mesh:

Year:  2015        PMID: 26084772     DOI: 10.1007/s00381-015-2756-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  10 in total

1.  Ophthalmoplegia in maple syrup urine disease.

Authors:  Balaji Gupta; Darrel Waggoner
Journal:  J AAPOS       Date:  2003-08       Impact factor: 1.220

2.  Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.

Authors:  Kenneth A Myers; Melanie Reeves; Xing-Chang Wei; Aneal Khan
Journal:  JIMD Rep       Date:  2011-09-22

3.  Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.

Authors:  T Tamiya; K Kinoshita; Y Ono; K Matsumoto; T Furuta; T Ohmoto
Journal:  Neuroradiology       Date:  2000-05       Impact factor: 2.804

4.  Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution.

Authors:  Sergio Rosemberg; Dirce Fujiwara
Journal:  Childs Nerv Syst       Date:  2005-07-26       Impact factor: 1.475

5.  Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.

Authors:  J Brismar; A Aqeel; G Brismar; R Coates; G Gascon; P Ozand
Journal:  AJNR Am J Neuroradiol       Date:  1990 Nov-Dec       Impact factor: 3.825

6.  Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.

Authors:  P S Bindu; K E Shehanaz; Rita Christopher; Pramod K Pal; S Ravishankar
Journal:  J Child Neurol       Date:  2007-07       Impact factor: 1.987

7.  MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.

Authors:  Wajanat Jan; Robert A Zimmerman; Zhiyue J Wang; Gerard T Berry; Paige B Kaplan; Edward M Kaye
Journal:  Neuroradiology       Date:  2003-05-08       Impact factor: 2.804

8.  Maple syrup urine disease in the Austronesian aboriginal tribe Paiwan of Taiwan: a novel DBT (E2) gene 4.7 kb founder deletion caused by a nonhomologous recombination between LINE-1 and Alu and the carrier-frequency determination.

Authors:  Ching-Shiang Chi; Chi-Ren Tsai; Liang-Hui Chen; Hsiu-Fen Lee; Betty Suk-Chun Mak; Shu-Hsuang Yang; Tsai-Yuh Wang; San-Ging Shu; Chao-Hui Chen
Journal:  Eur J Hum Genet       Date:  2003-12       Impact factor: 4.246

9.  Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease.

Authors:  W Heindel; H Kugel; U Wendel; B Roth; G Benz-Bohm
Journal:  Pediatr Radiol       Date:  1995

10.  Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system.

Authors:  Aditi Jain; K Jagdeesh; Ranoji Mane; Saurabh Singla
Journal:  J Clin Neonatol       Date:  2013-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.